Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Feb 06, 2026
Arm Holdings (ARM) Earnings Preview: AI Demand Drives Royalty Growth Amid Elevated Expectations

Arm Holdings (ARM) Earnings Preview: AI Demand Drives Royalty Growth Amid Elevated Expectations

Key Takeaways

  • Q3 Fiscal 2026 Revenue: Analysts expect $1.24B, up 25.7% YoY.

  • Consensus EPS: $0.41, a 2.5% increase from prior year, in line with company guidance.

  • Q2 Highlights: Record royalty revenue of $620M (+21%), boosted by AI demand in data centers and smartphones; licensing revenue surged 56% to $515M.

  • Guidance Alignment: Q3 revenue guidance of $1.225B ±$50M and non-GAAP EPS $0.41 ±$0.04 matches analyst expectations.

  • Investor Focus: Royalty growth from Armv9 architectures, Compute Subsystem (CSS) adoption, AI-driven licensing deals, and hyperscaler partnerships.

Why This Matters

Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.

Arm Holdings (ARM) broader semiconductor volatility, including U.S.-China trade tensions and cyclical handset pressures, this report will provide insight into Arm’s AI compute strategy, licensing execution, and trajectory toward fiscal 2026 targets.

Earnings Expectations

  • Revenue: $1.24B, +25.7% YoY (Zacks consensus), aligning with Arm’s guidance of $1.175–$1.275B.

  • EPS: $0.41 (non-GAAP), within $0.37–$0.45 company guidance.

  • Key Drivers:

    • Royalty revenue growth: Driven by Armv9 adoption in smartphones and data centers.

    • Licensing momentum: Compute Subsystem licenses now 19 across 11 customers.

    • AI exposure: Hyperscaler partnerships and enterprise chip adoption fueling recurring royalties.

Q2 revenue of $1.14B exceeded estimates, with royalty growth of 21% and licensing up 56%. Investors will monitor Q3 updates on v9 penetration, CSS adoption, and licensing timing, which directly influence high-margin royalty streams.

Market Reaction and Investor Sentiment

  • Valuation: Shares trade at ~48.6x forward EPS, roughly double the industry average, contributing to volatility.

  • Historical beats: Arm has four straight quarters of EPS surprises, averaging +11.1%, often triggering 6%+ premarket moves.

  • Risks: Timing of licensing deals, geopolitical exposure (China), and potential macro headwinds.

  • Sentiment: Cautiously optimistic—market pricing reflects strong AI expectations, but elevated multiples limit upside on modest beats.

Forward Outlook and Key Factors

Tickeron AI Perspective

Investors will closely track:

  1. Full-year fiscal 2026 guidance: Impacted by Q3 performance and Q4 outlook.

  2. Royalty revenue trends: Especially in AI-focused data centers (Neoverse) and smartphone CSS adoption.

  3. Licensing pipeline strength: Annualized contract value (ACV) growth signals future royalty visibility.

  4. AI initiatives: Partnerships with hyperscalers, automotive and IoT expansion, and next-gen architectures (Lumex CSS).

  5. Margins & R&D: Non-GAAP margin held at 41.1% despite 31% YoY R&D increase; free cash flow supports $2.67B liquidity.

  6. Geopolitical exposure: U.S. export controls on advanced tech to China could impact licensing.

Longer-term, Arm’s ecosystem moat—spanning premium smartphones and growing server adoption—positions it as a central player in AI compute. Execution on high-royalty segments and continued adoption of v9 and next-gen architectures will be critical for sustaining momentum into fiscal 2027.

Disclaimers and Limitations

Related Ticker: ARM

ARM's RSI Indicator recovers from oversold territory

The RSI Indicator for ARM moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 18 similar instances when the indicator left oversold territory. In of the 18 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARM advanced for three days, in of 193 cases, the price rose further within the following month. The odds of a continued upward trend are .

ARM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARM as a result. In of 46 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ARM moved below its 50-day moving average on July 13, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ARM crossed bearishly below the 50-day moving average on July 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ARM entered a downward trend on July 31, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (29.674) is normal, around the industry mean (15.194). P/E Ratio (244.582) is within average values for comparable stocks, (218.742). Projected Growth (PEG Ratio) (1.968) is also within normal values, averaging (1.896). ARM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (49.751) is also within normal values, averaging (41.978).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Analog Devices (NASDAQ:ADI), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 176.81B. The market cap for tickers in the group ranges from 13.43K to 4.86T. NVDA holds the highest valuation in this group at 4.86T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was -3%. For the same Industry, the average monthly price growth was -18%, and the average quarterly price growth was 36%. PI experienced the highest price growth at 19%, while NXPI experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was -14% and the average quarterly volume growth was -45%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 51
Price Growth Rating: 52
SMR Rating: 76
Profit Risk Rating: 74
Seasonality Score: -22 (-100 ... +100)
View a ticker or compare two or three
ARM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Semiconductors

Profile
Details
Industry
N/A
Address
110 Fulbourn Road
Phone
+44 1223400400
Employees
8330
Web
https://www.arm.com
Interact to see
Advertisement
Chevron’s upcoming Q4 report highlights its first full quarters integrating Hess, following record Q3 production of 4.1 million barrels of oil equivalent per day (MMboe/d). Comparing CVX with ExxonMobil and Shell provides insight into how each supermajor is navigating a volatile oil market with prices hovering below $60 per barrel.
SoFi Technologies is set to report Q4 and full-year 2025 earnings on January 30, 2026, closing out a pivotal year for the digital finance platform. With its fiscal year ending December 31, the report follows a strong Q3 that featured record net revenue of $962 million and member growth to 12.6 million, a 35% year-over-year increase.
ASML reported Q4 2025 net sales of $9.7 billion, gross margin of 52.2%, net income of $2.8 billion, and record net bookings of $13.2 billion, including $7.4 billion in EUV orders.
IDEXX Laboratories (IDXX) reports Q4 2025 earnings on February 2, 2026, with analysts expecting continued strength in recurring revenue from companion animal diagnostics. Danaher (DHR) reports on January 28, while Thermo Fisher Scientific (TMO) follows in early February, with both facing low-single-digit core growth expectations across life sciences and diagnostics.
NIO Inc. (NIO) produced its one-millionth vehicle this week at its Hefei facility, closing out a record 2025 delivery total of 326,028 units, up 46.9% year over year. The milestone, announced January 6, reflects accelerating demand for core models such as the ES8 SUV and newer brands ONVO and Firefly.
Faraday Future Intelligent Electric Inc. (FFAI) shares traded near $1.02 this week following announcements of a non-binding $10 million stock purchase term sheet with AIxCrypto (AIxC) and preparations for a Stockholders’ Day on January 7, 2026. Trading volume spiked amid broader EV volatility, highlighting investor attention on FFAI’s pivot toward AI-enhanced mobility and robotics.
BTQ Technologies Corp. (BTQ), formerly BTQQF, launched the Bitcoin Quantum testnet this week—the first quantum-safe Bitcoin fork, 17 years after Bitcoin’s genesis block. The move coincided with inclusion in the $524.5 million VanEck Quantum Computing UCITS ETF, boosting European investor visibility.
VEU targets large- and mid-cap ex-U.S. stocks with ~3,800 holdings. VXUS offers broad all-cap exposure, including ~8,600 stocks across small-, mid-, and large-cap companies.
Apple (AAPL) reports Q1 FY2026 earnings on January 29, with consensus revenue at $138.5B and EPS at $2.67, supported by strong demand for iPhone 17 models, higher average selling prices, and continued Services growth. Microsoft (MSFT) reports Q2 FY2026 on January 28, expecting $80.3B revenue and $3.91 EPS, driven by Azure AI adoption and enterprise cloud expansion, though elevated capex spending (~$35B/quarter) remains under scrutiny.
Visa Inc. (V), the global payments network leader, reports Q1 FY2026 earnings on January 29, 2026, for the period ending December 31, 2025. This marks the start of FY2026 following a strong FY2025, where net revenue reached $40 billion (+11%) and EPS climbed to $11.47 (+14%). Investors are watching closely for insights into consumer spending, cross-border travel recovery, and digital payment adoption.
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Arm Holdings (ARM) Earnings Preview: AI Demand Drives Royalty Growth Amid Elevated Expectations